Antiphospholipid Syndrome: all 121 studies
Page 1 of 2. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.
- Anticoagulant Cessation After Antiphospholipid Autoantibodies Loss in Thrombotic Antiphospholipid SyndromeNot yet recruitingNCT07875153Phase 3
- Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort StudyRecruitingNCT07757789Not applicable
- Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid SyndromeRecruitingNCT07743242Not applicable
- Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular ResearchNot yet recruitingNCT07737470
- Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)RecruitingNCT07584083Phase 2
- Point of Care Testing INR in Antiphospholipid SyndromeNot yet recruitingNCT07570511Not applicable
- YTS109 in Pediatric Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT07439029Phase 1
- Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS PatientsRecruitingNCT07372170
- Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune DiseasesRecruitingNCT07301164Early Phase 1
- Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune DeficienciesRecruitingNCT07251179
- Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune DiseasesRecruitingNCT07236801Phase 1
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingNCT07236762Phase 1
- A Study of CD19 UCAR-T Cells in Subjects With Autoimmune DiseasesNot yet recruitingNCT07212322Not applicable
- Follow-up Cohort of Patients With Antiphospholipid SyndromeRecruitingNCT07178925
- Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS)RecruitingNCT07163338Not applicable
- Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid SyndromeRecruitingNCT07142239
- A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune DiseasesRecruitingNCT07123519Phase 1
- Hematological Disorders in EHPVO PatientsNot yet recruitingNCT07108023
- A Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingNCT07104721Phase 1
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesRecruitingNCT07087912Phase 4
- Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune DiseasesRecruitingNCT07085676Phase 1
- A Clinical Study of YTS109 Cell in R/R Autoimmune DiseasesRecruitingNCT06978647Phase 1
- OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux DirectsNot yet recruitingNCT06929182
- DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort StudyNot yet recruitingNCT06884384
- Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune DiseasesRecruitingNCT06828042Phase 1/2
- Clinical Outcomes of Primary Versus Secondary Antiphospholipid SyndromeNot yet recruitingNCT06808607
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesRecruitingNCT06794008Phase 2
- Effect of Belimumab on Antibody Titers in Primary APS PatientsRecruitingNCT06747312Phase 2
- Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)Enrolling by invitationNCT06723106Phase 1
- Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune DiseasesRecruitingNCT06614270Not applicable
- The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control StudyNot yet recruitingNCT06504420Phase 2
- The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06420154Early Phase 1
- An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune DiseaseRecruitingNCT06379646Not applicable
- Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid SyndromeRecruitingNCT06373926Not applicable
- Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune DiseaseRecruitingNCT06373081Not applicable
- Negative Antiphospholipid Syndrome: a Multicentric StudyRecruitingNCT06373003
- Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)RecruitingNCT06371417Phase 1
- Anti-CD38 Antibody Treating APS With ThrombocytopeniaRecruitingNCT05983952Phase 2
- Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune DiseasesEnrolling by invitationNCT05859997Not applicable
- Daratumumab in Primary Antiphospholipid SyndromeRecruitingNCT05671757Phase 1/2
- Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APSRecruitingNCT05646394
- Telitacicept Followed With Rituximab Therapy on APS Secondary to SLERecruitingNCT05644210
- Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid SyndromeEnrolling by invitationNCT05583305
- Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworksRecruitingNCT05230017
- Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary ThrombocytopeniaRecruitingNCT05199909Phase 2
- Rheumatology Patient Registry and BiorepositoryRecruitingNCT04402086
- Laboratory and Clinical Data in Antiphospholipid PatientsRecruitingNCT04308564
- International Registry of Thrombotic APS Patients Treated With Direct Oral AnticoagulantsRecruitingNCT04262492
- Use of Warfarin After the First Trimester in Pregnant Women With APSRecruitingNCT02303171Phase 4
- Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally StudyRecruitingNCT00616317
- Genetic Risk Factors Associated With Antiphospholipid Antibody SyndromeRecruitingNCT00482794
- Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)RecruitingNCT00198068
- AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot StudyTerminatedNCT03100123Early Phase 1Results posted
- Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive PatientsTerminatedNCT01784523Phase 3Results posted
- Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid SyndromeCompletedNCT01051778Phase 2Results posted
- Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody SyndromeCompletedNCT01029587Phase 2Results posted
- Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome PatientsCompletedNCT00674297Phase 2Results posted
- A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid SyndromeCompletedNCT00537290Phase 2Results posted
- A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent ThrombosisActive, not recruitingNCT07632976Phase 1
- A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)WithdrawnNCT07172022Phase 2
- Effect of Telitacicept on Antibody Titers in Primary APS PatientsCompletedNCT06315530Phase 2
- Determination of Reference Values for Diluted Russell's Viper Venom Time (dRVVT) Specific to Pregnant Women (GRAPL)CompletedNCT06133621
- Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKEActive, not recruitingNCT05995600Phase 4
- Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type AnticoagulantCompletedNCT05416190Not applicable
- Placental Pathology and Inflammatory Factor Analysis of OAPSStatus unknownNCT05378516
- Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or VaccinationCompletedNCT05313048
- Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid SyndromeCompletedNCT05195372
- Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study)Status unknownNCT05128760
- Telitacicept in Primary APS PatientsTerminatedNCT05078710Phase 2
- Description of a Cohort of Covid-19 Patients With a Circulating AnticoagulantStatus unknownNCT05075928
- The BeLimumab Antiphospholipid Syndrome Trial (BLAST)Status unknownNCT05020782Phase 2/3
- A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid SyndromeStatus unknownNCT04624269Phase 4
- Obstetric Antiphospholipid Antibody Syndrome : Contribution of the Evaluation of ADAMTS13 Made at the Diagnosis of Pregnancy on Evaluation the Risk of Pre-eclampsiaCompletedNCT04319341
- HYDROxychloroquine in Syndrome Primary AntiPhospholipidWithdrawnNCT04275778Phase 2
- Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?WithdrawnNCT04274803Phase 4
- Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid SyndromeCompletedNCT04153201Not applicable
- Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)CompletedNCT03994302
- Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS)CompletedNCT03969498
- Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
- Prevalence of Antiphospholipid Antibodies in the Hemodialysis Patients Population Within the CHU Brugmann HospitalCompletedNCT03893357
- New Biological Tests in Patients With Antiphospholipid AntibodiesCompletedNCT03890601
- RIvaroxaban for Stroke Patients With AntiPhospholipid SyndromeCompletedNCT03684564Phase 2
- Evaluation of Precision and Accuracy of INR Measurements in a Point of Care DeviceCompletedNCT03682419
- Medium-term Follow-up of Patients With Obstetric Antiphospholipid Syndrome: MRI Study of White MatterCompletedNCT03600636Not applicable
- Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid SyndromeStatus unknownNCT03540810Phase 3
- The Value of Placental Vascularization and Placental Volume in Pregnancy in APLSStatus unknownNCT03505840
- Ocular Findings in Women With Primary Antiphospholipid SyndromeCompletedNCT03459508
- Prevalence of Lysosomal Hydrolase Alpha-glagtosidase Deficiency in Patients With Antiphospholipid Syndrome.Status unknownNCT03384485Not applicable
- Multi-organ Screening for Asymptomatic Ischaemia in Antiphospholipid SyndromeCompletedNCT03348306Not applicable
- Measurement of Anti-dsDNA by Both CLIFT & ELISAStatus unknownNCT03303508Not applicable
- Rivaroxaban for Patients With Antiphospholipid SyndromeCompletedNCT02926170Phase 3
- Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)CompletedNCT02892565Not applicable
- The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International RecommendationsCompletedNCT02855047
- Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid SyndromeCompletedNCT02833194
- Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)CompletedNCT02782039
- Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid SyndromeTerminatedNCT02595346Phase 2
- Phenomics in Autoimmune and Inflammatory DiseasesCompletedNCT02466217
- Pregnancy and Medically Assisted Conception in Rare DiseasesWithdrawnNCT02450396
- Timing of Initiation of LMWH Administration in Pregnant Women With APSCompletedNCT02326051Phase 4
- Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid SyndromeCompletedNCT02295475Phase 4